Fusion Antibodies gets first order under new services agreement
27th Feb 2024 13:15
(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.
Read moreFusion Antibodies raises £1.38m as it seeks new customers
14th Feb 2024 12:52
(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.
Read moreFusion Antibodies confirms £0.28m tax credit
1st Feb 2024 16:27
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.
Read moreFusion Antibodies revenue falls, losses widen in first half
4th Dec 2023 12:01
(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.
Read moreFusion Antibodies appoints interim finance chief
24th Aug 2023 14:45
(Sharecast News) - Preclinical antibody developer Fusion Antibodies announced the immediate appointment of Stephen Smyth as its interim chief financial officer on Thursday.
Read moreFusion Antibodies progresses AI antibody collaboration
21st Aug 2023 13:43
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.
Read moreContract suspensions see Fusion Antibodies warn on revenue
6th Mar 2023 16:26
(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.
Read moreFusion Antibodies confident after 'challenging' first half
5th Dec 2022 16:28
(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenues of £1.9m on Monday, down from £2.4m year-on-year.
Read moreFusion Antibodies reports strong full-year revenue growth
6th May 2022 12:52
(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies reported 14% growth in revenue in a trading update on Friday, to £4.8m.
Read moreFusion Antibodies forms new scientific advisory panel
14th Jan 2022 14:15
(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies announced the formation of a new scientific advisory panel (SAP) of experts on Friday, to support research and development across its range of antibody services, and to provide advice regarding emerging science and technology issues and trends.
Read moreRevenues rise, losses widen for Fusion Antibodies
6th Dec 2021 11:59
(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.
Read moreFusion Antibodies signs collaborative deal with US biotech firm
7th Oct 2021 11:59
(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.
Read moreFusion Antibodies performing in line in year-to-date
24th Sep 2021 11:55
(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.
Read moreRevenues rise, losses widen for Fusion Antibodies
10th Aug 2021 12:44
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.
Read moreFusion Antibodies receives first research milestone payment
23rd Jul 2021 09:32
(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.
Read more